Your patients can now face melasma head-on with PicoWay® treatments.
PicoWay, the ultra-short pulse, photoacoustic laser technology from Candela, introduces new treatment indications, including the treatment of melasma.
Melasma is a complex skin disorder that often needs a multi-treatment approach to manage its waxing and waning qualities. The PicoWay system gives healthcare providers a new tool for patients struggling to clear the often-unsettling pigmentation changes they experience.
The PicoWay system is well-established in treating benign pigmented lesions, offering a revolutionary solution that breaks down excess pigment under the skin without impacting or overheating outer skin layers. The PicoWay laser can be used on all skin types, including darker skin types, who are frequently impacted by this condition.
In addition to receiving FDA clearance for melasma, indications for lentigines, Nevus of Ota, and Café au Lait Macules were also added to the growing list of PicoWay laser clearances.
Other indications include:
With four true picosecond wavelengths and versatile beam delivery technologies, PicoWay is truly leading the way in picosecond solutions. 
Contact a Candela representative today to learn more.